Camurus launches Oczyesa in Germany for patients with acromegaly

Zhimeng starts CB03-154 phase 2/3 clinical trial

Akeso's ivonescimab in combination with chemotherapy granted Breakthrough Therapy Designation in China

GC Biopharma's Phase 2 clinical trial results for BARYTHRAX published in Vaccine

Kiora Pharmaceuticals joins Global Genes' RARE-X Vision Consortium

Pilatus Biosciences to present new preclinical data on PLT012 at SITC 2025

Rovia Clinical Research opens new clinical research site in Hattiesburg, Mississippi

ChemDiv extends CMC services collaboration supporting clinical development of ratutrelvir

NeuroKaire and Compass Pathways partner to advance AI-driven research in psychedelic psychiatry

BioArctic reports third-quarter royalties from Leqembi sales

GenSight Biologics secures FDA authorisation for expanded access to GS010/LUMEVOQ in the US

AnHorn Medicines reports positive results from US Phase I trial of AH-001

ArkBio commences Phase II clinical trial of AK0610

Curasight advances Phase 2 prostate cancer trial with Curium partnership

European Commission approves Merck's KEYTRUDA (pembrolizumab) for resectable head and neck cancer expressing PD-L1